Actively Recruiting
Study of Ursodeoxycholic Acid to Prevent Recurrence of Clostridioides difficile Colitis Alongside Standard Antibiotic Treatment
Led by Medical College of Wisconsin · Updated on 2026-11-02
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This trial investigates whether Ursodeoxycholic Acid UDCA can help prevent the recurrence of Clostridioides difficile C. diff colitis in adults who have risk factors for the infection returning. Researchers aim to find out if adding UDCA to standard antibiotic treatments reduces the chance of C. diff coming back, lowers the need for repeated antibiotics, and whether UDCA is safe and well-tolerated. C. diff colitis is a serious infection with a high recurrence rate, and current antibiotic treatments can disrupt gut bacteria, increasing risk of reinfection. Participants will receive standard antibiotic treatment, which may include Vancomycin, Fidaxomicin, or Metronidazole, along with UDCA at a dose of 500 mg three times daily for up to eight weeks. Treatment with UDCA will start while patients are on antibiotics. If stool tests show no C. diff at four weeks, participants will stop UDCA early. Researchers will monitor stool samples at the start, at four weeks, and at the end of treatment, with additional tests if diarrhea occurs. Throughout the study, participants will be contacted weekly by phone to check for side effects and ensure adherence to the treatment plan. Researchers will measure whether C. diff recurs within eight weeks and three months. The study includes adults at least 18 years old with a positive C. diff test who are receiving antibiotics. People with severe or life-threatening C. diff, serious liver disease, limited life expectancy, or who are pregnant or breastfeeding, will not be eligible. The total study duration includes treatment and follow-up for six months.
CONDITIONS
Brief Title
Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy
Research Team
D
Daniel Stein, MD
H
Helmut Ammon, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here